MMS’ Acquisition Of Exploristics Ltd

Osborne Clarke advised the majority shareholders of Exploristics Ltd on the sale. MMS, an award-winning, data-focused clinical research organization (CRO), announced its acquisition of Exploristics, a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here